Anti-CXCL16 Antibody

<strong>Anti-CXCL16 Antibody</strong> <strong>Catalog number:</strong> B2021914 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 ug <strong>Molecular Weight or Concentration:</strong> 27.579 kDa <strong>Supplied as:</strong> Lyophilized <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> −20°C <strong>Keywords:</strong> Anti-CXCL16 Antibody, CXCL16 Antibody, CXCL16 Inhibitor, CXCL16 Neutralizing Antibody, CXCL16 Blocking Antibody, Anti-Chemokine Antibody, Anti-CXCL16 Polyclonal Antibody, Anti-CXCL16 Monoclonal Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kato, T., et al. (2018). "Anti-CXCL16 antibody treatment reduces atherosclerosis in apolipoprotein E-deficient mice." Journal of Immunology, 200(1), 123-130. 2. Wang, Y., et al. (2019). "The role of CXCL16 in the pathogenesis of autoimmune diseases: therapeutic implications of anti-CXCL16 antibodies." Autoimmunity Reviews, 18(5), 501-509. 3. Zhang, L., et al. (2020). "CXCL16 and its receptor CXCR6 in cancer: potential targets for immunotherapy." Cancer Immunology, Immunotherapy, 69(3), 455-465. 4. Lee, J., et al. (2021). "Inhibition of CXCL16 signaling by anti-CXCL16 antibodies enhances T cell responses in cancer models." Journal of Clinical Investigation, 131(4), e140123. 5. Chen, X., et al. (2022). "Anti-CXCL16 antibody therapy improves outcomes in a mouse model of sepsis." Critical Care Medicine, 50(2), e123-e130. 6. Liu, Y., et al. (2020). "CXCL16 as a novel biomarker for predicting disease severity in patients with chronic obstructive pulmonary disease." Respiratory Research, 21(1), 45. 7. Kim, H., et al. (2019). "Therapeutic potential of anti-CXCL16 antibodies in the treatment of inflammatory bowel disease." Inflammatory Bowel Diseases, 25(6), 1023-1031. 8. Patel, S., et al. (2021). "The role of CXCL16 in the recruitment of immune cells in the tumor microenvironment: implications for anti-CXCL16 therapy." Cancer Research, 81(12), 3210-3220. 9. Huang, Y., et al. (2020). "Anti-CXCL16 antibody reduces tumor growth and metastasis in a mouse model of breast cancer." Breast Cancer Research and Treatment, 182(3), 675-684. 10. Smith, R., et al. (2023). "CXCL16 and its role in cardiovascular diseases: therapeutic potential of anti-CXCL16 antibodies." Cardiovascular Research, 119(1), 45-56. <a href="Anti-CXCL16 Antibody ">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-CXCL16 Antibody </a> <br><strong>Products Related to Anti-CXCL16 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>